Evaluation of the Metabolic Response to Cyclopamine Therapy in Pancreatic Cancer Xenografts Using a Clinical PET-CT System
about
(18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application.In vivo (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography imaging of pancreatic tumors in a transgenic rat model carrying the human KRAS(G12V) oncogene.Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling.Combined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1α signaling axis.
P2860
Evaluation of the Metabolic Response to Cyclopamine Therapy in Pancreatic Cancer Xenografts Using a Clinical PET-CT System
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Evaluation of the Metabolic Re ...... Using a Clinical PET-CT System
@en
type
label
Evaluation of the Metabolic Re ...... Using a Clinical PET-CT System
@en
prefLabel
Evaluation of the Metabolic Re ...... Using a Clinical PET-CT System
@en
P2093
P2860
P356
P1476
Evaluation of the Metabolic Re ...... Using a Clinical PET-CT System
@en
P2093
Bettina Kraenzlin
Christian Fink
Hany Kayed
Maliha Sadick
Norbert Gretz
Patrick Meyer
P2860
P304
P356
10.1593/TLO.12166
P577
2012-10-01T00:00:00Z